Skip to main content

From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.

Publication ,  Conference
Bao, X; Liu, X; Hu, M; Chang, H; Jiao, M; Cheng, J; Xie, L; Huang, Q; Li, F; Li, C-Y
Published in: CANCER RESEARCH
2021

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

13

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bao, X., Liu, X., Hu, M., Chang, H., Jiao, M., Cheng, J., … Li, C.-Y. (2021). From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. In CANCER RESEARCH (Vol. 81).
Bao, Xuhui, Xinjian Liu, Mengjie Hu, Hanman Chang, Meng Jiao, Jin Cheng, Liyi Xie, Qian Huang, Fang Li, and Chuan-Yuan Li. “From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.” In CANCER RESEARCH, Vol. 81, 2021.
Bao X, Liu X, Hu M, Chang H, Jiao M, Cheng J, et al. From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. In: CANCER RESEARCH. 2021.
Bao X, Liu X, Hu M, Chang H, Jiao M, Cheng J, Xie L, Huang Q, Li F, Li C-Y. From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. CANCER RESEARCH. 2021.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

13

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis